Vasostatin inhibits VEGF-induced endothelial cell proliferation, tube formation and induces cell apoptosis under oxygen deprivation

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6019-6030

  Shu, Qun ^a   Li, Wenjiao ^a   Li, Haichuan ^a   Sun, Gang ^b  

^a Shanghai Changning Maternity and Infant Health Hospital   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Human umbilical vein endothelial cells (HUVEC); Mitochondrial apoptosis; Vasostatin

Indexed keywords

CALRETICULIN; CASPASE 3; CASPASE 8; CYCLIN D3; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASOSTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXYGEN; PEPTIDE FRAGMENT; VASCULOTROPIN A;

AFFINITY CHROMATOGRAPHY; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MORPHOGENESIS; MTT ASSAY; OPTICAL DENSITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALRETICULIN; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898667116     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046019     Document Type: Article

References (34)

1. Folkman, J. Angiogenesis: Initiation and control. Ann. N. Y. Acad. Sci. 1982, 401, 212-227.
2. Hanahan, D.; Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353-364.
3. Shojaei, F. Anti-angiogenesis therapy in cancer: Current challenges and future perspectives. Cancer Lett. 2012, 320, 130-137.
4. Pike, S.E.; Yao, L.; Jones, K.D.; Cherney, B.; Appella, E.; Sakaguchi, K.; Nakhasi, H.; Teruya-Feldstein, J.; Wirth, P.; Gupta, G. et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 1998, 188, 2349-2356.
5. Yao, L.; Pike, S.E.; Setsuda, J.; Parekh, J.; Gupta, G.; Raffeld, M.; Jaffe, E.S.; Tosato, G. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. Blood 2000, 96, 1900-1905.
6. Pike, S.E.; Yao, L.; Setsuda, J.; Jones, K.D.; Cherney, B.; Appella, E.; Sakaguchi, K.; Nakhasi, H.; Atreya, C.D.; Teruya-Feldstein, J. et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999, 94, 2461-2468.
7. Xiao, F.; Wei, Y.; Yang, L.; Zhao, X.; Tian, L.; Ding, Z.; Yuan, S.; Lou, Y.; Liu, F.; Wen, Y. et al. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther. 2002, 9, 1207-1213.
8. Tonra, J.R.; Hicklin, D.J. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. Immunol. Investig. 2007, 36, 3-23.
9. Dudley, A.C. Tumor endothelial cells. Cold Spring Harb. Perspect. Med. 2012, 2, doi:10.1101/cshperspect.a006536.
10. Bogdanov, A.A., Jr.; Lin, C.P.; Kang, H.W. Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody. Pharm. Res. 2007, 24, 1186-1192.
11. Lamalice, L.; le Boeuf, F.; Huot, J. Endothelial cell migration during angiogenesis. Circ. Res. 2007, 100, 782-794.
12. Diermeier-Daucher, S.; Clarke, S.T.; Hill, D.; Vollmann-Zwerenz, A.; Bradford, J.A.; Brockhoff, G. Cell type specific applicability of 5-ethynyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry. Cytom. Part A 2009, 75, 535-546.
13. Garcia-Cardena, G.; Fan, R.; Shah, V.; Sorrentino, R.; Cirino, G.; Papapetropoulos, A.; Sessa, W.C. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392, 821-824.
14. Gentile, C.; Muise-Helmericks, R.C.; Drake, C.J. VEGF-mediated phosphorylation of eNOS regulates angioblast and embryonic endothelial cell proliferation. Dev. Biol. 2013, 373, 163-175.
15. Patel, J.M. Calreticulin Regulation of Lung Endothelial NOS Activity; Landes Bioscience: Austin, TX, USA, 2000; pp. 205-219.
16. Chiba, R.; Nakagawa, N.; Kurasawa, K.; Tanaka, Y.; Saito, Y.; Iwamoto, I. Ligation of CD31 (PECAM-1) on endothelial cells increases adhesive function of alphavbeta3 integrin and enhances beta1 integrin-mediated adhesion of eosinophils to endothelial cells. Blood 1999, 94, 1319-1329.
17. Gallo, M.P.; Levi, R.; Ramella, R.; Brero, A.; Boero, O.; Tota, B.; Alloatti, G. Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H2906-H2912.
18. Wu, P.C.; Yang, L.C.; Kuo, H.K.; Huang, C.C.; Tsai, C.L.; Lin, P.R.; Shin, S.J.; Tai, M.H. Inhibition of corneal angiogenesis by local application of vasostatin. Mol. Vis. 2005, 11, 28-35.
19. Huegel, R.; Velasco, P.; de la, Luz Sierra, M.; Christophers, E.; Schroder, J.M.; Schwarz, T.; Tosato, G.; Lange-Asschenfeldt, B. Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. J. Investig. Dermatol. 2007, 127, 65-74.
20. Mans, S.; Banz, Y.; Mueller, B.U.; Pabst, T. The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patients. Blood 2012, 120, 2690-2699.
21. Halestrap, A.P.; Doran, E.; Gillespie, J.P.; O'Toole, A. Mitochondria and cell death. Biochem. Soc. Trans. 2000, 28, 170-177.
22. Mazars, A.; Geneste, O.; Hickman, J. The Bcl-2 family of proteins as drug targets. J. Soc. Biol. 2005, 199, 253-265.
23. Miller, D.K. The role of the Caspase family of cysteine proteases in apoptosis. Semin. Immunol. 1997, 9, 35-49.
24. MacLauchlan, S.; Yu, J.; Parrish, M.; Asoulin, T.A.; Schleicher, M.; Krady, M.M.; Zeng, J.; Huang, P.L.; Sessa, W.C.; Kyriakides, T.R. Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2. Proc. Natl. Acad. Sci. USA 2011, 108, E1137-E1145.
25. Rudic, R.D.; Shesely, E.G.; Maeda, N.; Smithies, O.; Segal, S.S.; Sessa, W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Investig. 1998, 101, 731-736.
26. Yu, J.; deMuinck, E.D.; Zhuang, Z.; Drinane, M.; Kauser, K.; Rubanyi, G.M.; Qian, H.S.; Murata, T.; Escalante, B.; Sessa, W.C. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc. Natl. Acad. Sci. USA 2005, 102, 10999-11004.
27. Murohara, T.; Witzenbichler, B.; Spyridopoulos, I.; Asahara, T.; Ding, B.; Sullivan, A.; Losordo, D.W.; Isner, J.M. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1156-1161.
28. Yao, L.; Pike, S.E.; Tosato, G. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function. J. Leukoc. Biol. 2002, 71, 47-53.
29. Junttila, M.R.; de Sauvage, F.J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013, 501, 346-354.
30. Dembinska-Kiec, A.; Polus, A.; Kiec-Wilk, B.; Grzybowska, J.; Mikolajczyk, M.; Hartwich, J.; Razny, U.; Szumilas, K.; Banas, A.; Bodzioch, M. et al. Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. Biochim. Biophys. Acta 2005, 1740, 222-239.
31. Im, E.; Venkatakrishnan, A.; Kazlauskas, A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol. Biol. Cell 2005, 16, 3488-3500.
32. Shen, J.; Qu, C.K. In vitro hematopoietic differentiation of murine embryonic stem cells. Methods Mol. Biol. 2008, 430, 103-118.
33. Kaur, S.; Kumar, T.R.; Uruno, A.; Sugawara, A.; Jayakumar, K.; Kartha, C.C. Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: An in vitro study. Basic Res. Cardiol. 2009, 104, 739-749.
34. Qiao, T.; Liu, C.J.; Ran, F.; Han, L.; Zhang, L.; Li, L. Experimental study of recombinant eukaryotic expression vector of human eNOS in ECV304. Swiss Med. Wkly. 2006, 136, 19-25.